Trial Outcomes & Findings for Gastric Outlet Obstructions Tailored Covered Stents for GOO (NCT NCT02299258)

NCT ID: NCT02299258

Last Updated: 2015-02-12

Results Overview

number of participants considered having efficacious outcome. Efficacy is defined by Ingrowth + overgrowth in this study

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

63 participants

Primary outcome timeframe

up to 5 years

Results posted on

2015-02-12

Participant Flow

Participant milestones

Participant milestones
Measure
Tailored Stents MTN-WE-20/100-A
The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane. Tailored stents MTN-WE-20/100-A: cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Standard Stents MTN-CG-s-20/100
Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm Standard stents MTN-CG-s-20/100: The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
Overall Study
STARTED
32
31
Overall Study
COMPLETED
31
30
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Gastric Outlet Obstructions Tailored Covered Stents for GOO

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Tailored Stents MTN-WE-20/100-A
n=32 Participants
The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane. Tailored stents MTN-WE-20/100-A: cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Standard Stents MTN-CG-s-20/100
n=31 Participants
Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm Standard stents MTN-CG-s-20/100: The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
Total
n=63 Participants
Total of all reporting groups
Age, Continuous
76.4 years
STANDARD_DEVIATION 7.7 • n=5 Participants
75.8 years
STANDARD_DEVIATION 7.6 • n=7 Participants
76.1 years
STANDARD_DEVIATION 7.7 • n=5 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
32 Participants
n=5 Participants
31 Participants
n=7 Participants
63 Participants
n=5 Participants
Sex: Female, Male
Female
14 Participants
n=5 Participants
15 Participants
n=7 Participants
29 Participants
n=5 Participants
Sex: Female, Male
Male
18 Participants
n=5 Participants
16 Participants
n=7 Participants
34 Participants
n=5 Participants
Region of Enrollment
China
32 participants
n=5 Participants
31 participants
n=7 Participants
63 participants
n=5 Participants
Gastric outlet obstruction score
3.2 units on a scale
n=5 Participants
3.1 units on a scale
n=7 Participants
3.2 units on a scale
n=5 Participants

PRIMARY outcome

Timeframe: up to 5 years

number of participants considered having efficacious outcome. Efficacy is defined by Ingrowth + overgrowth in this study

Outcome measures

Outcome measures
Measure
Tailored Stents MTN-WE-20/100-A
n=32 Participants
The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane. Tailored stents MTN-WE-20/100-A: cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Standard Stents MTN-CG-s-20/100
n=31 Participants
Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm Standard stents MTN-CG-s-20/100: The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
Efficiency of Stents
1 participants
7 participants

SECONDARY outcome

Timeframe: up to 5 years

bleeding, abdominal pain

Outcome measures

Outcome measures
Measure
Tailored Stents MTN-WE-20/100-A
n=32 Participants
The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane. Tailored stents MTN-WE-20/100-A: cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Standard Stents MTN-CG-s-20/100
n=31 Participants
Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm Standard stents MTN-CG-s-20/100: The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
Adverse Events
25 participants
4 participants

Adverse Events

Tailored Stents MTN-WE-20/100-A

Serious events: 25 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Stents MTN-CG-s-20/100

Serious events: 4 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Tailored Stents MTN-WE-20/100-A
n=32 participants at risk
The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane. Tailored stents MTN-WE-20/100-A: cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Standard Stents MTN-CG-s-20/100
n=31 participants at risk
Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm Standard stents MTN-CG-s-20/100: The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
Blood and lymphatic system disorders
Bleeding
34.4%
11/32 • Number of events 11
6.5%
2/31 • Number of events 2
Gastrointestinal disorders
Abdominal pain
40.6%
13/32 • Number of events 13
3.2%
1/31 • Number of events 1
Gastrointestinal disorders
Food impaction
3.1%
1/32 • Number of events 1
3.2%
1/31 • Number of events 1

Other adverse events

Adverse event data not reported

Additional Information

Dr.Ding Shi

The First People's Hospital of Yuhang District

Phone: +8657189369162

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place